| N = 109 | |
---|---|---|
Patient characteristics | n | mean (SD) |
Sex (male/female) | 54/55 | Â |
Age (years) | Â | 52.8 (14.2) |
Duration of spasticity symptoms (years) | ||
 1–5 years | 21 |  |
 6–10 years | 21 |  |
 11–15 years | 16 |  |
  > 15 years | 51 |  |
 Genetic defect | 57 |  |
 SPG-3a | 4 |  |
 SPG-4 | 36 |  |
 SPG-5a | 2 |  |
 SPG-7 | 3 |  |
 SPG-8 | 3 |  |
 SPG-10 | 2 |  |
 SPG-17 | 1 |  |
 SPG-31 | 5 |  |
 SPG-72 | 1 |  |
Positive family history | ||
 First degree relatives | 83 |  |
 Other family members | 47 |  |
 First degree relatives and/or other family members | 90 |  |
 Unknown | 8 |  |
 No | 11 |  |
Non-neurological comorbidities | ||
 Asthma/COPD | 6 |  |
 Diabetes | 1 |  |
 Hypertension | 9 |  |
 Joint disorders* | 13 |  |
 Cardiac problems | 4 |  |
 Other non-neurological comorbidities | 7 |  |